Perils of non-family managers
A former Toyota exec blasts non-family managers for the company’s problems. Are some Indianapolis-area companies better-
or worse-off after families relinquished control?
Health Care & Life Sciences
Articles
House approves smoking ban in public places
The House has approved legislation that would ban smoking in public places statewide except casinos and pari-mutuel horse
racing venues.
WellPoint CEO blames health costs for hikes
Amid attacks from Democrats over high executive salaries, Angela Braly testified in Washington, D.C., on Wednesday that big
insurance-premium increases are
the result of growing price tags for hospital care and pharmaceuticals.
California lawmakers question Anthem about rate hikes
California lawmakers grilled Anthem Blue Cross executives on Tuesday about their plan to boost individual insurance premiums
by as much as 39 percent, only to hear them blame the economy and a broken health care system.
Obama health reform plan slaps drugmakers
Drugmakers, such as Indianapolis-based Eli Lilly and Co., would shoulder $3.3 billion in fees, face ban on pay-for-delay deals
with generic competitor.
WellPoint testimony drops green flag on health reform restart
CEO Angela Braly is defending individual premium hikes one day before Obama's summit to debate his new reform proposal
with Republicans.
Medco profit rises as mail-order generics business grows
The pharmacy benefits manager, which has major operations in Whitestown, said fourth quarter profit rose 24 percent.
WellPoint to face questioning over rate hike
Executives are scheduled to testify Tuesday before a California legislative committee and on Wednesday before a U.S. House
of Representatives committee about big premium increases.
Lilly, Merck, Pfizer starting research center
Three major U.S. drugmakers said they have formed a not-for-profit company in Asia to focus on cancer research and treatments.
California regulator finds Anthem Blue Cross violations
California’s insurance regulator said Monday his office has found more than 700 violations by the state’s largest for-profit
health insurer, a subsidiary of Indianapolis-based WellPoint.
WellPoint gets tax delay in Obama health plan
Insurers WellPoint Inc. and others would get a delay in taxes on premiums and high-cost medical benefits, along with additional
funding for expanding Medicaid, under a White House proposal
Obama endorses new taxes, more drugmaker fees
Obama, seeking to break an impasse over health-care legislation, proposes a plan that includes the first Medicare tax on unearned
income such as capital gains and higher fees on drugmakers.
Insurers warn of problems with federal regulator
President Obama’s latest push for a health care overhaul could drive health plans around the country into insolvency, according
to an insurance trade group.
New Obama health proposal would limit rate hikes
President Barack Obama is making a fresh attempt to rescue his health care overhaul by proposing a measure that would allow
the government to deny or roll back egregious insurance premium increases that infuriate consumers.
A closer look at WellPoint’s health insurance profits
At the heart of the debate is the question of what should be a fair profit for health insurers. WellPoint CEO Angela Braly
will likely be grilled on the issue when she appears at a Congressional hearing Wednesday.
White House plans new rules for health insurers
President Obama will release a proposal to restart the health-care debate before a bipartisan White House meeting on Feb.
25, one day after WellPoint officials testify before Congress about steep rate increases.
Teva gets European OK to sell generic of Lilly’s Evista
Evista generated $1.03 billion in sales last year, of which $348.1 million came outside the United States.
Lilly asks shareholders to lower takeover barrier
Eli Lilly and Co. directors have recommended that shareholders toss out the
drugmaker's most potent protection against unwanted takeovers: an 80-percent supermajority vote threshold for any shareholder
mutiny to succeed.
WellPoint’s health insurance rate hike spurs legislative inquiry
The furor over WellPoint Inc.’s premium hikes have migrated from California to Indiana, where state lawmakers held a
high-profile hearing.
Indiana companies that serve pharmaceutical industry grew in 2009
The firms continued to grow over the last year but face increasing challenges, according to a new report by Indianapolis-based
life sciences trade group BioCrossroads.